Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the CD79A Test Immunohistochemistry is typically 3-5 business days.

What are the prerequisites for the test CD79A Test Immunohistochemistry

  • Formalin-fixed, paraffin-embedded tissue sections
  • Antigen retrieval solution (e.g. citrate buffer)
  • Primary antibody against CD79A
  • Secondary antibody conjugated to HRP or AP
  • Enzyme substrate for HRP or AP detection
  • Counterstain (e.g. hematoxylin)
  • Mounting medium
  • Microscope

What are the measure values for the test CD79A Test Immunohistochemistry

  • Positive: Strong membranous staining in >30% of tumor cells
  • Weak positive: Weak membranous staining in <30% of tumor cells
  • Negative: No membranous staining or staining in <10% of tumor cells

What does this test CD79A Test Immunohistochemistry identify?

  1. CD79A Test Immunohistochemistry:

    This test identifies the presence of CD79A protein in tissue samples through immunohistochemistry. CD79A is a protein that is part of the B-cell receptor complex and is expressed on the surface of B cells. Detection of CD79A can indicate the presence of B-cell lymphomas, leukemias, and other B-cell related disorders. Immunohistochemistry involves using antibodies to specifically bind to the CD79A protein in tissue sections, allowing for visualization of the protein's location and distribution within the sample.

Why is this test CD79A Test Immunohistochemistry taken?

CD79A Test Immunohistochemistry is taken to detect the presence of CD79A protein in tissues. CD79A is a protein that is expressed on the surface of B-cells, a type of white blood cell that plays a key role in the immune response. By performing this test, healthcare providers can determine if a patient has abnormal levels of CD79A protein, which may indicate certain types of blood cancers, such as B-cell lymphomas or leukemias.

Popular FAQs on Test

CD79A Test Immunohistochemistry is a diagnostic test that detects the presence of CD79A protein in tissue samples, typically used to identify B cell lymphomas.
CD79A Test Immunohistochemistry is performed to aid in the diagnosis of B cell lymphomas and to guide treatment decisions.
The CD79A Test Immunohistochemistry is performed on tissue samples obtained through biopsy or surgery. The tissue samples are stained with specific antibodies that bind to the CD79A protein, allowing for visualization under a microscope.
CD79A Test Immunohistochemistry is a minimally invasive procedure and typically does not pose any significant risks or complications. However, as with any medical procedure, there is a small risk of infection or bleeding at the biopsy site.
There is usually no special preparation required for CD79A Test Immunohistochemistry. However, it is important to inform your healthcare provider about any medications you are taking, as some medications may interfere with the test results.

Customer Google Rating